Background. Attempts to identify noninvasive markers of ventricular dysfunction accompanying acute rejection have been hampered by a lack of detailed simultaneous hemodynamic data. Therefore, we prospectively performed serial monitoring of detailed left and right heart hemodynamic parameters in cardiac transplant recipients at the time of routine endomyocardial biopsy to better define the physiology of the allograft heart during and after acute rejection.
Methods and Results. To better assess the pathophysiology of the rejection process, 18 cardiac transplant patients were prospectively studied by serial right heart micromanometer catheterization and digital image processing at the time of routine endomyocardial biopsy. Eleven patients had 18 episodes of rejection. Studies of baseline (negative biopsy preceding rejection), rejection (acute moderate rejection), and resolved (first negative biopsy after rejection) states were compared. Seven patients who did not experience an episode of rejection served as the control group. Right ventricular minimum and end-diastolic pressures increased from baseline values of 0.9+3.2 and 6.9±3.7 mm Hg, respectively, to 3.2+5.5 and 9.9±6.6 mm Hg, respectively, with rejection (both variables, p <0.05) and remained elevated despite histological resolution of rejection (4.3±5.5 and 10.0±7.1 mm Hg, respectively; p<0.05 for both variables compared with baseline values). Concurrently, right ventricular end-diastolic volumes (133+29, 119±27, and 114±30 ml; baseline, rejection, and resolved, respectively) and left ventricular end-diastolic volumes (133+24, 117+20, and 113±30 ml; baseline, rejection, and resolved, respectively) significantly decreased during rejection and remained decreased after resolution of rejection (rejection and resolved compared with baseline values,p<0.05). Right ventricular chamber stiffness (0.055±0.035,0.085±0.057, and 0.092±0.076 mm Hg/ml; baseline, rejection, and resolution, respectively; rejection and resolved compared with baseline values, p<0.05) increased with rejection and remained elevated after resolution of rejection. Right ventricular peak filling rate also increased from a baseline value of 2.48+0.45 to 2.76+0.63 ml end-diastolic volumes per second with rejection (p<0.05). Elevation of right ventricular filling pressures, peak filling rate, and chamber stiffness with a concomitant decrease in end-diastolic volume is consistent with a restrictive/constrictive physiology. Mean arterial blood pressure and systemic vascular resistance were elevated after the resolution of rejection (compared with either rejection or baseline values,p <0.05) associatedwith a higher mean daily dose of prednisone (resolved compared with either baseline or rejection values, p<0.0S). The control group experienced a time-dependent increase in mean and diastolic systemic arterial pressures (both comparisons, p<0.05) without detectable diastolic dysfunction. Attempts to identify noninvasive markers of ventricular dysfunction accompanying acute rejection have been hampered by a lack of detailed simultaneous hemodynamic data. Therefore, we prospectively performed serial monitoring of detailed left and right heart hemodynamic parameters in cardiac transplant recipients at the time of routine endomyocardial biopsy to better define the physiology of the allograft heart during and after acute rejection.
Conclusions

Methods
Patient Demographics
Eighteen patients who underwent orthotopic cardiac transplantation were studied prospectively (1-13 months after transplant) at the time of routine endomyocardial biopsy. The patients received standard triple immunosuppressive therapy (cyclosporin, azathioprine, and prednisone with OKT3 monoclonal antibody induction given for 14 days after surgery). Rejection episodes were treated with pulsed steroid doses and tapered oral prednisone therapy. Cyclosporin levels were not adjusted because of the presence or absence of acute rejection. Fifteen patients (83%) were men, and three (17%) were women. Ages at time of transplantation were 27-59 years (mean, 45.9 years). Six patients (33%) underwent initial transplantation for idiopathic cardiomyopathy, 11 (61%) for ischemic heart disease, and one (6%) 
Hemodynamics
Systemic arterial pressure was measured by automated cuff (Dynamap). A balloon flotation micromanometer thermodilution catheter (75 Hz frequency response) (El Camino Labs, San Diego, Calif.) was introduced via the right internal jugular vein. All right heart pressures were measured relative to the level of the right atrium in the following manner: After external calibration, the tip of the micromanometer was advanced into the right atrium where the height of the external fluid-filled catheter transducer was adjusted until the mean fluid-filled catheter pressure equaled the micromanometer pressure, indicating that the exact height of the right atrium had been determined.14 After subsequent advancement of the catheter, the micromanometer pressure reading was offset to yield a mean pressure equal to that of the fluidfilled catheter. This procedure ensured that differences in pressure measured by the micromanometer were not because of varying hydrostatic anteroposterior positions within the body. Right ventricular, right atrial, pulmonary artery, and pulmonary capillary wedge pressures (mm Hg) were measured with the micromanometer, and pulmonary and systemic vascular resistances (PVR and SVR; dyne/sec/cm-5) were calculated. Triplicate determinations of cardiac output (CO; 1/min), cardiac index (CI; I/min/m2), and stroke volume (SV; ml) were made by thermodilution.
Imaging Protocol
Intravenous ventriculography was performed in a General Electric MPX single-plane angiographic suite under fluoroscopy with constant amperage (mA) and voltage (kV[P]). Analog fluoroscopic images were displayed on a black-and-white Conrac 16-in. monitor and recorded on a 3/4-in. Sony 5800 U-matic broadcast-quality VCR recorder. Digital image processing was performed as previously described15 with a Gould Deanza IP 8500 image processor linked to a Vax 11/780 processor. A Techstore high-speed disk served as a real-time storage device for the digitized and processed images.
Nonionic iodinated contrast medium (Isovue) was injected (15 ml/sec for 3 seconds) into the superior vena cava using a power injector (Medrad). The injection was filmed in a 300 right anterior oblique projection under fluoroscopy at 30 frames/sec during held midinspiration, including several preinjection beats, until complete levophase left ventricular opacification could be seen. Baseline ECG and right ventricular pressures were recorded after FM modulation on the VCR audio channels before ventriculography. Left and right ventricular opacification images, right ventricular pressure, and ECG signal recordings were digitized on the Vax 11/780 processor with the use of a 7.5 -MHz analog/digital conversion board. The cycle chosen for analysis was the optimally opacified beat, and no attempt was made to control for recipient atrial timing. Digital subtraction and pixel-by-pixel analysis of 512x512 (8-bit 256 grey scale) images were performed on the 1P8500 and the Techstore high-speed disk. Ejection fraction was determined for both ventricles by a method previously validated in our laboratory15 and elsewhere'6 using a secondary background subtraction curve ( Figure 1 ). Relative volume-time curves derived from logarithmic transformation and integration of video intensity over the ventricular silhouette were normalized to enddiastolic volume, smoothed with a four-harmonic algorithm, and interpolated to approximately 200 points (10 per frame) ( Figure 2 ). The first derivative of this curve ( Figure 2 ) was used to determine peak and time-to-peak ejection and filling rates (PER and PFR, end-diastolic volumes per second; TPER and TPFR, msec). End-diastolic volumes for both ventricles were calculated as thermodilution stroke volume divided by ejection fraction. Right ventricular chamber stiffness was calculated as end-diastolic pressure divided by end-diastolic volume.17
Rejection Studies
Eighteen episodes of acute moderate rejection occurred in 11 patients. Nine of these represented the first clinical episode of acute moderate rejection. Hemodynamics were monitored for each patient as described during each biopsy. The first study was the last histologically negative biopsy that preceded an episode of moderate acute rejection.18 The second study was the episode associated with acute moderate rejection. The last study was the first subsequent biopsy free of any rejection (cellular infiltrates) following the moderate rejection. These studies were designated baseline, rejection, and resolved, respectively. The median time between baseline and rejection studies was 8 days, 33 days between rejection and resolved studies, and 58 days between baseline and resolved studies. One of the baseline studies demonstrated mild (infiltrative) rejection because of the lack of a preceding true-negative biopsy. Data for the resolved study were not obtained in one patient because of the patient's death before resolution of rejection. In a second patient, data for the resolved study were not obtained because of the lack of a true-negative biopsy before a subsequent episode of acute moderate rejection. Control Studies Seven patients did not manifest an episode of acute moderate rejection during the study period and formed the control group. Two representative studies of serial hemodynamic monitoring were analyzed for each patient, selected so that the time interval between the studies was similar to that between the baseline and resolved studies in the rejection group. Median time between the two studies was 62 days.
Statistics
All hemodynamic data are expressed as mean +1 Ventriculography. Ejection fraction did not significantly vary for either ventricle with the onset or resolution of rejection (see Table 2 
Discussion
To our knowledge, this is the first study to describe detailed hemodynamic changes in both right and left ventricular function during rejection as well as resolution of rejection. Right ventricular diastolic and minimum pressures rose significantly with rejection and remained elevated despite histological resolution of rejection by endomyocardial biopsy. Right ventricular systolic pressure also rose during rejection but returned to baseline after resolution of rejection. Right ventricular peak filling rate was significantly higher with rejection, consistent with a restrictive/ constrictive physiology,19 whereas left ventricular peak filling rate was relatively unchanged. Calculated end-diastolic volumes for both ventricles were significantly lower, and right ventricular chamber stiffness was significantly higher during and after rejection. Mean, systolic, and diastolic systemic arterial pressures and SVR all increased significantly in the period after rejection, associated with a significantly larger mean daily dose of prednisone increased to treat the preceding rejection episode. These hemodynamic changes were not seen in the control group, although a time-dependent increase in mean and diastolic systemic arterial pressures was noted.
Despite relatively normal heart function after cardiac transplantation, minor chronic hemodynamic dysfunction is typically present in the transplant patient, possibly related to perioperative ischemia and reperfusion injury, hypertension, drug therapy, and/or rejection changes.10"1320 Greenberg Orthotopic cardiac transplantation places significant functional burden on the right ventricle. Right ventricular dilatation and remodeling, associated with pulmonary hypertension, have been documented.23 Latent right ventricular restrictive/constrictive patterns that appear with rapid volume infusion also exist.'3 These ventricular abnormalities may in part be related to myocardial fibrosis as well as to specific postoperative right ventricular enlargement because of preexisting heart failure-related increased pulmonary vascular resistance.
Previous studies have documented left ventricular diastolic hemodynamic changes during rejection in the transplanted heart. Griepp et al12 were the first investigators to describe diastolic dysfunction associated with acute rejection after cardiac transplantation12; however, hemodynamic parameters were not reported. Dawkins et a19 and Valantine et al8 observed a shortened isovolumic relaxation time and pressure half-time by echocardiography in the left ventricle during rejection. Paulsen et a17 noted prolonged duration of rapid diastolic filling with rejection, also indicative of abnormal diastolic function. Although Dawkins et al reported that isovolumic relaxation time returned to baseline after the resolution of acute rejection, a subsequent study by Valantine et al'0 showed that diastolic dysfunction, associated with increased frequency of myocardial rejection episodes, may be cumulative and not completely reversible.
In models of rejection, myocyte dysfunction due solely to leukocyte cytokines, such as tumor necrosis factor and interleukin-1 released during acute moderate rejection,24 would be expected to be reversible. Nevertheless, failure of right ventricular minimum and end-diastolic pressures to return to baseline values after resolution of rejection supports Valantine et al's hypothesis that rejection causes possible cumulative and irreversible damage to the myocardium.10 Our observations that end-diastolic volumes for both ventricles decrease and right ventricular chamber stiffness increases during rejection (and remain abnormal even after resolution of rejection by biopsy) indicate that elevated filling pressures are probably caused by the loss of mechanical ventricular distensibility instead of by volume loading or other glucocorticoid effects,1323 which would be expected to be accompanied by an increase in end-diastolic ventricular volume and unchanged right ventricular chamber stiffness. Hypertrophy of surviving myocytes might play a role in the preservation of systolic function after acute moderate rejection, but irrevers- Alternately, persistent right ventricular diastolic dysfunction after histological resolution of rejection may be in part related to ventricular interdependent effects. Elevated systemic blood pressures associated with increased prednisone therapy after histological resolution of rejection might lead to diastolic dysfunction of both ventricles that would be difficult to distinguish from primary myocardial changes.25 Nevertheless, time-dependent increases in systemic arterial blood pressure without measurable diastolic dysfunction seen in the albeit small control population may indicate that a primary myocardial change does occur and that hypertension alone is not responsible for the effects seen in the rejection group.
Increased peak filling rate has been observed as a consequence of restrictive/constrictive physiology. 19 Our observation that right ventricular peak filling rate is elevated during rejection whereas left ventricular peak filling rate is relatively unchanged agrees with previous clinical suggestions that the right ventricle is more sensitive to diastolic rejection changes than the left ventricle.1-13 The thinner and dilated right ventricle, already affected by early postoperative pulmonary hypertension,23 may have less functional reserve than the left ventricle and may be more sensitive to changes that accompany rejection. FibroSiS21 and possible ischemic changes caused by graft atherosclerosis26 are also possible contributors to chronic diastolic dysfunction.
Increased systemic arterial pressures and systemic vascular resistance at the time of histological resolution of rejection have not been specifically noted in the literature. Daily mean prednisone doses are significantly higher during this time for the treatment 
